Company profilePharmaceutical#464 of 1,318 in Pakistan✓ No DRAP alerts

Ashrafsons Pharmaceutical (Pvt) Ltd.

Pharmaceutical company · 32 brands · 30 molecules

32 registered products 27 pharmaceutical brands 30 distinct molecules 0 DRAP alerts

Company overview

32
registered products
27
pharmaceutical brands
30
distinct molecules
0
therapeutic classes
0
DRAP alerts

Ashrafsons Pharmaceutical (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 32 product registrations across 30 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Ashrafsons

31 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

31
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202531

Top molecules by brand count

Glucose ...... 5 Gm2 brands
Metronidazole ...... 500 Mg1 brand
Calcium Chloride ...... 0.27 G1 brand
Calcium Chloride ...... 0.027 G1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official48 products · Rs 10.52 – Rs 252.51
Median across source: Rs 111.03

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

FRONTIER DEXTROSE LIMITED10 shared molecules
NEUTRO PHARMA (PVT) LTD.10 shared molecules
GALLOP WATER SCIENCES9 shared molecules
JHK PHARMA (PVT) LTD8 shared molecules
Medipak (Pvt) Ltd7 shared molecules
Otsuka Pakistan Limited6 shared molecules
GEOFMAN PHARMACEUTICALS5 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

FRONTIER DEXTROSE LIMITED holds 18 molecules not in this portfolio
ChlorideCiprofloxacinDextrose 4.3%Dextrose 5%Dextrose Iv SolutionLevofloxacin
NEUTRO PHARMA (PVT) LTD. holds 121 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
GALLOP WATER SCIENCES holds 9 molecules not in this portfolio
CiprofloxacinDextrose 5%Dextrose Iv SolutionIpratropium.LevofloxacinLignocaine

Get the full profile for Ashrafsons

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.